Enhancing Treatment of Iron Deficiency and Iron Deficiency Anemia With an Antioxidant, Vitamin E
Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
The study addresses treatment of iron deficiency, the most common nutritional deficiency that
infants and young children encounter. With the knowledge that iron deficiency may
irreversibly affect a baby's long-term neurodevelopment and behavior, the investigators are
offering free screening blood draws at Children's Hospital Colorado to older babies and
toddlers (9-24 months old). If their blood results indicate a serum ferritin of ≤ 15
micrograms/dL without the presence of an elevated C-reactive protein (CRP), they will be
invited to continue in the intervention portion of the study, where they will receive iron
supplements as well as vitamin E (or placebo) for an eight week treatment period. The
rationale for the study is to test whether addition of Vitamin E, an antioxidant and
anti-inflammatory agent, improves the treatment response to supplemental iron.
Phase:
Phase 1
Details
Lead Sponsor:
University of Colorado, Denver
Treatments:
alpha-Tocopherol Antioxidants Iron Tocopherols Tocotrienols Vitamin E Vitamins